tiprankstipranks
Ardelyx Inc (CH:41X)
NASDAQ:41X
Switzerland Market
41X
Ardelyx
RESEARCH TOOLSreports

Ardelyx (41X) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

41X Analyst Ratings

Strong Buy
6Ratings
Strong Buy
6 Buy
0 Hold
0 Sell
Based on 6 analysts giving stock ratings to
Ardelyx
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

41X Stock 12 Month Forecast

Average Price Target

$13.00
Based on 6 Wall Street analysts offering 12 month price targets for Ardelyx in the last 3 months. The average price target is $13.00 with a high forecast of $15.28 and a low forecast of $10.45. The average price target represents a ― change from the last price of ―.
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
Highest Price Target$15.28Average Price Target$13.00Lowest Price Target$10.45
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on CH:41X
Dennis Ding
Jefferies
Jefferies
CHF12.06
Buy
―
Reiterated
06/26/26
Jefferies says Ardelyx CMS appeal loss 'shouldn't fundamentally change anything'Jefferies says Ardelyx CMS appeal loss 'shouldn't fundamentally change anything'
Wedbush Analyst forecast on CH:41X
Unknown Analyst
Wedbush
Not Ranked
Wedbush
CHF15.28
Buy
―
Reiterated
05/01/26
Wedbush Remains a Buy on Ardelyx (ARDX)
Piper Sandler Analyst forecast on CH:41X
Allison Bratzel
Piper Sandler
Piper Sandler
CHF12.87
Buy
―
Reiterated
05/01/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Pacira Pharmaceuticals (NASDAQ: PCRX), Merit Medical Systems (NASDAQ: MMSI) and Ardelyx (NASDAQ: ARDX)
H.C. Wainwright Analyst forecast on CH:41X
Matthew Caufield
H.C. Wainwright
H.C. Wainwright
CHF14.48
Buy
―
Reiterated
05/01/26
Analyst Reiterates Buy on Ardelyx, Citing Tenapanor Momentum and Pipeline Upside with Unchanged $18 Price Target
TD Cowen Analyst forecast on CH:41X
Joseph Thome
TD Cowen
TD Cowen
CHF10.45
Buy
―
Reiterated
04/30/26
Analysts Offer Insights on Healthcare Companies: Ardelyx (NASDAQ: ARDX) and Summit Therapeutics (NASDAQ: SMMT)
BTIG Analyst forecast on CH:41X
Julian Harrison
BTIG
BTIG
CHF13.67
Buy
―
Reiterated
02/20/26
Ardelyx (ARDX) Receives a Buy from BTIG
Citi Analyst forecast on CH:41X
Yigal Nochomovitz
Citi
Citi
CHF8.85→CHF11.26
Buy
―
Reiterated
01/08/26
Ardelyx price target raised to $14 from $11 at CitiArdelyx price target raised to $14 from $11 at Citi
Raymond James Analyst forecast on CH:41X
Christopher Raymond
Raymond James
Raymond James
CHF12.87→CHF15.28
Buy
―
Reiterated
01/08/26
Ardelyx price target raised to $19 from $16 at Raymond JamesArdelyx price target raised to $19 from $16 at Raymond James
Scotiabank Analyst forecast on CH:41X
Louise Chen
Scotiabank
Scotiabank
CHF12.06
Buy
―
Reiterated
08/05/25
Scotiabank Sticks to Its Buy Rating for Ardelyx (ARDX)
Leerink Partners Analyst forecast on CH:41X
Roanna Ruiz
Leerink Partners
Leerink Partners
CHF8.04→CHF8.85
Buy
―
Reiterated
08/05/25
Ardelyx's Strong Financial Performance and Strategic Positioning Drive Buy Rating and Increased Price Target
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on CH:41X
Dennis Ding
Jefferies
Jefferies
CHF12.06
Buy
―
Reiterated
06/26/26
Jefferies says Ardelyx CMS appeal loss 'shouldn't fundamentally change anything'Jefferies says Ardelyx CMS appeal loss 'shouldn't fundamentally change anything'
Wedbush Analyst forecast on CH:41X
Unknown Analyst
Wedbush
Not Ranked
Wedbush
CHF15.28
Buy
―
Reiterated
05/01/26
Wedbush Remains a Buy on Ardelyx (ARDX)
Piper Sandler Analyst forecast on CH:41X
Allison Bratzel
Piper Sandler
Piper Sandler
CHF12.87
Buy
―
Reiterated
05/01/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Pacira Pharmaceuticals (NASDAQ: PCRX), Merit Medical Systems (NASDAQ: MMSI) and Ardelyx (NASDAQ: ARDX)
H.C. Wainwright Analyst forecast on CH:41X
Matthew Caufield
H.C. Wainwright
H.C. Wainwright
CHF14.48
Buy
―
Reiterated
05/01/26
Analyst Reiterates Buy on Ardelyx, Citing Tenapanor Momentum and Pipeline Upside with Unchanged $18 Price Target
TD Cowen Analyst forecast on CH:41X
Joseph Thome
TD Cowen
TD Cowen
CHF10.45
Buy
―
Reiterated
04/30/26
Analysts Offer Insights on Healthcare Companies: Ardelyx (NASDAQ: ARDX) and Summit Therapeutics (NASDAQ: SMMT)
BTIG Analyst forecast on CH:41X
Julian Harrison
BTIG
BTIG
CHF13.67
Buy
―
Reiterated
02/20/26
Ardelyx (ARDX) Receives a Buy from BTIG
Citi Analyst forecast on CH:41X
Yigal Nochomovitz
Citi
Citi
CHF8.85→CHF11.26
Buy
―
Reiterated
01/08/26
Ardelyx price target raised to $14 from $11 at CitiArdelyx price target raised to $14 from $11 at Citi
Raymond James Analyst forecast on CH:41X
Christopher Raymond
Raymond James
Raymond James
CHF12.87→CHF15.28
Buy
―
Reiterated
01/08/26
Ardelyx price target raised to $19 from $16 at Raymond JamesArdelyx price target raised to $19 from $16 at Raymond James
Scotiabank Analyst forecast on CH:41X
Louise Chen
Scotiabank
Scotiabank
CHF12.06
Buy
―
Reiterated
08/05/25
Scotiabank Sticks to Its Buy Rating for Ardelyx (ARDX)
Leerink Partners Analyst forecast on CH:41X
Roanna Ruiz
Leerink Partners
Leerink Partners
CHF8.04→CHF8.85
Buy
―
Reiterated
08/05/25
Ardelyx's Strong Financial Performance and Strategic Positioning Drive Buy Rating and Increased Price Target
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BBOTBridgeBio Oncology Therapeutics
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
MLYSMineralys Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals Inc
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Ardelyx

3 Months
Yigal NochomovitzCiti
Success Rate
9/17 ratings generated profit
53%
Average Return
+27.72%
Copying Yigal Nochomovitz's trades and holding each position for 3 Months would result in 52.94% of your transactions generating a profit, with an average return of +27.72% per trade.
1 Year
Christopher RaymondRaymond James
Success Rate
8/16 ratings generated profit
50%
Average Return
+27.07%
Copying Christopher Raymond's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +27.07% per trade.
2 Years
Yigal NochomovitzCiti
Success Rate
8/17 ratings generated profit
47%
Average Return
+92.11%
Copying Yigal Nochomovitz's trades and holding each position for 2 Years would result in 47.06% of your transactions generating a profit, with an average return of +92.11% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

41X Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
12
8
6
8
5
Buy
2
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
14
8
6
8
5
In the current month, 41X has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 41X average Analyst price target in the past 3 months is 13.00.
Each month's total comprises the sum of three months' worth of ratings.

41X Financial Forecast

41X Earnings Forecast

Next quarter’s earnings estimate for 41X is -$0.03 with a range of -$0.07 to $0.00. The previous quarter’s EPS was -$0.12. 41X beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year 41X has Performed in-line its overall industry.
Next quarter’s earnings estimate for 41X is -$0.03 with a range of -$0.07 to $0.00. The previous quarter’s EPS was -$0.12. 41X beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year 41X has Performed in-line its overall industry.

41X Sales Forecast

Next quarter’s sales forecast for 41X is $101.09M with a range of $90.45M to $110.25M. The previous quarter’s sales results were $75.97M. 41X beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year 41X has Performed in-line its overall industry.
Next quarter’s sales forecast for 41X is $101.09M with a range of $90.45M to $110.25M. The previous quarter’s sales results were $75.97M. 41X beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year 41X has Performed in-line its overall industry.

41X Stock Forecast FAQ

What is CH:41X’s average 12-month price target, according to analysts?
Based on analyst ratings, Ardelyx Inc’s 12-month average price target is 13.00.
    What is CH:41X’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:41X, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Ardelyx Inc a Buy, Sell or Hold?
        Ardelyx Inc has a consensus rating of Strong Buy, which is based on 6 buy ratings, 0 hold ratings and 0 sell ratings.
          What is Ardelyx Inc’s share price target?
          The average share price target for Ardelyx Inc is 13.00. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $15.28 ,and the lowest forecast is $10.45. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Ardelyx Inc?
            Ardelyx Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.
              How can I buy shares of Ardelyx Inc?
              To buy shares of CH:41X, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.